LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹4.85 Cr | ₹2.24 Cr | ₹5.91 Cr | ₹7.82 Cr | ₹-3.17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LASA SUPERGENERICS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹4.85 Cr |
Mar2023 | ₹2.24 Cr |
Mar2022 | ₹5.91 Cr |
Mar2021 | ₹7.82 Cr |
Mar2020 | ₹-3.17 Cr |
How is Deferred Tax Assets / Liabilities of LASA SUPERGENERICS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.85 Cr | 116.91 | |
Mar2023 | ₹2.24 Cr | -62.20 | |
Mar2022 | ₹5.91 Cr | -24.42 | |
Mar2021 | ₹7.82 Cr | Positive | |
Mar2020 | ₹-3.17 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹130.1 Cr | 0.7% | -10.4% | -19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | 0.7% |
-10.4% |
-19.2% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses